延安必康(002411.SZ):與南京國資混改基金旗下觀有資本簽署戰略合作協議
格隆匯11月10日丨延安必康(002411.SZ)公佈,公司(“甲方”)於2021年11月10日與南京觀有股權投資有限公司(“乙方”)簽署《戰略合作協議》。觀有資本是南京國資混改基金下屬基金管理公司,曾先後發起設立紫金醫藥、紫金普拓、紫金巨石、紫金觀萃、觀乾民發和南京新興零售等六隻股權投資基金(或有限合夥企業),受託管理基金總規模近90億元。
目前,受整體融資環境等因素影響,甲方存在一定流動性壓力,現有資金難以充分滿足新能源、新材料、醫藥板塊的戰略發展需求。為及時把握新能源、新材料、醫藥產業的發展窗口期,甲方與乙方擬達成合作關係,藉助甲方的產業優勢、乙方的資金優勢及資源優勢,雙方實現互惠互利、資源共享、優勢互補,共同推進甲方相關產業的發展。雙方經協商一致,達成戰略合作協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.